Company Financials

Corcept Therapeutics Incorporated Financials

United States dollar

business Corcept Therapeutics Incorporated Company Profile

Main Stock Listing

NASDAQ: CORT

Market Capitalization $4.03 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 43.91
Forward PE 55.20
Price to Sales TTM $5.43
Price to Book MRQ $6.36
Enterprise to Revenue 4.38
Enterprise to EBITDA 48.65

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 14.32%
Operating Margin 4.92%
Return on Assets TTM 5.10%
Return on Equity TTM 16.70%

Income Statement

Revenue TTM $741,171,968
Revenue per Share TTM $7.14
Quarterly Revenue Growth 13.70%
Gross Profit TTM $727,784,000
EBITDA $67,440,000
Net Income to Common TTM $104,656,000
Diluted EPS TTM $0.87
Quarterly Earnings Growth YoY -58.30%

Balance Sheet

Total Cash MRQ $421,683,008
Total Cash per Share MRQ $4.01
Total Debt MRQ $
Total Debt to Equity MRQ 1.01
Current Ratio MRQ 3.14
Book Value per Share MRQ $6.01

Cash Flow

Operating Cash Flow TTM $163,378,000
Levered Free Cash Flow TTM $135,722,496

CORT Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 105,124,000
Float Shares 86,968,566
Avg 10 Volume 3,878,354
Avg 30 Volume None
Shares Short 10,108,719
Short Ratio 13.94
Short % of Shares 12.99%
% Held by Insiders 11.57%
% Held by Institutions 75.47%

Stock Price Summary

Beta 0.20
Fifty Two Week Low $32.99
Fifty Two Week High $117.33
Fifty Two Week Change -35.24%
Day 50 MA $77.62
Day 200 MA $73.92

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date